Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels (Q33496258)

27 July 2017

title

Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels (English)

1 reference

27 July 2017

Samer O Abdul-Hay

1

1 reference

27 July 2017

Praneeth Edirisinghe

series ordinal

2

1 reference

27 July 2017

Gregory R J Thatcher

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

22 August 2009

1 reference

Journal of Neurochemistry

27 July 2017

published in

1 reference

27 July 2017

volume

111

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

683-695

1 reference

Inflammation and Alzheimer's disease

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The current status of Alzheimer's disease genetics: what do we tell the patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Therapeutic potential of nitrate esters of commonly used drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Molecular genetics of Alzheimer's disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Pharmacogenomics and therapeutic prospects in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Dominance of amyloid precursor protein sequence over host cell secretases in determining beta-amyloid profiles studies of interspecies variation and drug action by internally standardized immunoprecipitation/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

An update on the amyloid hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The role of amyloid beta peptide 42 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

ApoE promotes the proteolytic degradation of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Semiquantitative analysis of amyloid beta peptides using a combination of immunoprecipitation and matrix-assisted laser desorption ionization/ time-of-flight-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Abeta40 inhibits amyloid deposition in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta(beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Substrate-targeting gamma-secretase modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The disordered neuronal cytoskeleton in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Anti-inflammatory drugs in the fight against Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Abeta-degrading enzymes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Selective inhibition of Abeta42 production by NSAID R-enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The amyloid-beta precursor protein: integrating structure with biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Clearance of amyloid-beta by circulating lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß 42 by Inhibiting Rho

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2009.06355.X

10.1111/J.1471-4159.2009.06355.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference